Adoptive therapy with purified CD8 cells in HIV infection.
Herberman
R B
RB
Pittsburgh Cancer Institute, PA.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy; D016827:CD8 Antigens / Q000032:analysis; D003131:Combined Modality Therapy; D003602:Cytotoxicity, Immunologic; D006678:HIV / Q000502:physiology; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000627:therapeutic use; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000637:transplantation*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000637:transplantation*; D014182:Transplantation, Autologous; D014779:Virus Replication
D016827:CD8 Antigens; D007376:Interleukin-2